CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity

被引:4
|
作者
Ando, Yayoi [1 ,2 ]
Maeshima, Akiko Miyagi [1 ]
Fukuhara, Suguru [2 ]
Makita, Shinichi [2 ]
Munakata, Wataru [2 ]
Suzuki, Tatsuya [2 ]
Maruyama, Dai [2 ]
Taniguchi, Hirokazu [1 ]
Izutsu, Koji [2 ]
机构
[1] Natl Canc Ctr, Div Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Dept Hematol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
关键词
CD3; CD56; Epstein-Barr virus; Nasal cavity; Plasmacytoma; EPSTEIN-BARR-VIRUS; PLASMABLASTIC LYMPHOMA; SOLITARY PLASMACYTOMA; IMMUNOCOMPETENT; DIAGNOSIS; NEOPLASMS; FEATURES; TUMORS;
D O I
10.1007/s12185-018-2438-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a case of atypical extraosseous plasmacytoma (EP) with a plasmablastic morphology and CD3(+) CD56(+) Epstein-Barr virus-encoded RNA-1 (EBER1)(+) phenotypes of the nasal cavity. A 51-year-old male attended a local hospital with a tumor located in his left nasal cavity that was histologically diagnosed as extranodal NK/T cell lymphoma, nasal type. We reviewed the specimens and re-biopsied the tumor, and confirmed that the tumor was positive for CD3, CD56, and EBER1; however, the tumor showed a plasmablastic morphology without necrosis and angiocentricity, and was positive for CD138, but negative for CD20 and PAX5. Given a plasmablastic morphology and EBER1 positivity, but a relatively low Ki67 index (30%), we diagnosed the case as atypical EP. The CHOP regimen was administered and complete remission achieved. This case indicated that EP should be considered as a differential diagnosis even when a tumor shows large cell morphology and is positive for CD3, CD56, and EBER1.
引用
收藏
页码:344 / 347
页数:4
相关论文
共 50 条
  • [21] AUTOMATED ISOLATION OF LYMPHOID (CD3+, CD19+, CD56+) AND MYELOID (CD33/CD66B+, CD15+) SUBSETS FOR USE IN LINEAGE -SPECIFIC CHIMERISM ANALYSIS
    McQueen, Karina
    Dixon, Jason
    Liew, Jasmine
    Peters, Carrie
    Thomas, Terry
    HUMAN IMMUNOLOGY, 2017, 78 : 243 - 243
  • [22] CD3+/CD56+ NKT-like Cells Show Imbalanced Control Immediately after Exercise in Delayed-Onset Muscle Soreness
    Sonkodi, Balazs
    Pallinger, Eva
    Radovits, Tamas
    Csulak, Emese
    Shenker-Horvath, Kinga
    Kopper, Bence
    Buzas, Edit, I
    Sydo, Nora
    Merkely, Bela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [23] A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand
    RT Costello
    S Sivori
    F Mallet
    D Sainty
    C Arnoulet
    D Reviron
    J-A Gastaut
    A Moretta
    D Olive
    Leukemia, 2002, 16 : 855 - 860
  • [24] A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand
    Costello, RT
    Sivori, S
    Mallet, F
    Sainty, D
    Arnoulet, C
    Reviron, D
    Gastaut, JA
    Moretta, A
    Olive, D
    LEUKEMIA, 2002, 16 (05) : 855 - 860
  • [25] CD3+, CD56+, CD4-, CD8-, CD20-, CD30-Peripheral T-Cell Non-Hodgkin′s Lymphoma: A Rare Case Report
    Jagati, Ashish
    Shah, Bela J.
    Tibrewal, Soria
    Gajjar, Trusha
    INDIAN JOURNAL OF DERMATOLOGY, 2017, 62 (02) : 200 - 202
  • [26] Expression of CD3ε, CD3ζ, and RAG-1/RAG-2 in decidual CD56+ NK cells
    King, A
    Gardner, L
    Sharkey, A
    Loke, YW
    CELLULAR IMMUNOLOGY, 1998, 183 (02) : 99 - 105
  • [27] COMPARATIVE-STUDIES OF CD3- AND CD3+ CD56+ CELLS - EXAMINATION OF MORPHOLOGY, FUNCTIONS, T-CELL RECEPTOR REARRANGEMENT, AND PORE-FORMING PROTEIN EXPRESSION
    ORTALDO, JR
    WINKLERPICKETT, RT
    YAGITA, H
    YOUNG, HA
    CELLULAR IMMUNOLOGY, 1991, 136 (02) : 486 - 495
  • [28] CD3+ CD56+ natural killer T cell activity in children with different forms of juvenile idiopathic arthritis and the influence of etanercept treatment on polyarticular subgroup
    Zhou, Juan
    Ding, Yuan
    Zhang, Yu
    Feng, Ye
    Tang, Xuemei
    Zhao, Xiaodong
    CLINICAL IMMUNOLOGY, 2017, 176 : 1 - 11
  • [29] Induction or a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancy
    Engel, BC
    Laws, HJ
    Buttlies, B
    Kahn, T
    Gobel, U
    Burdach, SEG
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (02): : 56 - 60
  • [30] CD3+/CD56+ EBV+ neoplasms in the nose and upper aerodigestive tract: potential misdiagnosis of plasma cell malignancies as NK/T cell lymphoma
    Rex Au-Yeung
    Florence Loong
    Yok-Lam Kwong
    Annals of Hematology, 2021, 100 : 1101 - 1104